Fetal cardiac evaluation at 11-14 weeks by experienced obstetricians in a low-risk population

Prenat Diagn. 2011 Nov;31(11):1054-61. doi: 10.1002/pd.2831. Epub 2011 Jul 29.

Abstract

Objective: The aim of this study was to evaluate the detection rate of congenital heart diseases (CHD) in a low-risk population by performing cardiac evaluation during the first-trimester screening for chromosomal abnormalities. In this context, the role of four-chamber view, tricuspid regurgitation and abnormal ductus venosus flow in the screening for cardiac anomalies in a low-risk population was also investigated.

Method: The cardiac examination was performed by obstetricians with extensive experience in first- and second-trimester ultrasound (US). Follow-up US evaluations during the second and third trimesters were offered to all patients. In case of abnormal findings during routine assessment, fetal echocardiography was performed by a fetal cardiologist.

Results: Among the 4445 fetuses included in the study, 42 CHD were detected (39 diagnosed prenatally and 3 postnatally). In 27 cases, the fetal cardiologist confirmed the type of CHD diagnosed at US screening. In 1 case, the diagnosis was slightly different in the second trimester, and in 3 of the 26 correctly diagnosed in the first-trimester cases, the CHD developed and progressed in severity. A significant association of major CHD and US first-trimester markers was observed.

Conclusions: First-trimester assessment of the fetal heart is feasible in a low-risk population when performed by experienced obstetricians. However, although most types of CHD can be diagnosed early in pregnancy, some may become apparent later in gestation.

MeSH terms

  • Adult
  • Chorionic Gonadotropin / blood
  • Chromosome Aberrations
  • Female
  • Fetal Diseases / diagnosis*
  • Fetal Diseases / physiopathology
  • Fetal Heart / abnormalities*
  • Fetal Heart / diagnostic imaging
  • Fetal Heart / physiopathology
  • Gestational Age
  • Heart Defects, Congenital / diagnosis*
  • Heart Defects, Congenital / epidemiology
  • Heart Defects, Congenital / physiopathology
  • Humans
  • Obstetrics / methods*
  • Pregnancy
  • Pregnancy Trimester, First / blood
  • Pregnancy-Associated Plasma Protein-A / metabolism
  • Prospective Studies
  • Ultrasonography, Prenatal*

Substances

  • Chorionic Gonadotropin
  • Pregnancy-Associated Plasma Protein-A